// COMPANY
Delix Therapeutics
SECTOR BIOTECHMENTIONS 1LAST SEEN AUGUST 24, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·Axios Pro Rata·AUGUST 24, 2026
“Delix Therapeutics, a Boston-based developer of psychoplastogens, raised $85m in Series C funding led by J&J.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.